首页> PloS one> Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.

导出 OA

翻译打印收藏纠错

第一作者： Sherif A,Ibrahim

第一单位： Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany ; Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt.

作者： Sherif A,Ibrahim ^[1] ; Hebatallah,Hassan ^[1] ; Laura,Vilardo ^[2] ; Sampath Katakam,Kumar ^[3] ; Archana Vijaya,Kumar ^[3] ; Reinhard,Kelsch ^[4] ; Cornelia,Schneider ^[3] ; Ludwig,Kiesel ^[3] ; Hans Theodor,Eich ^[5] ; Ileana,Zucchi ^[2] ; Rolland,Reinbold ^[2] ; Burkhard,Greve ^[5] ; Martin,Götte ^[3]

作者单位： Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany ; Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt. ^[1] ITB-CNR, Segrate Milan, Italy. ^[2] Department of Gynecology and Obstetrics, University Hospital Münster, Münster, Germany. ^[3] Institute of Transfusion Medicine and Transplantation Immunology, University Hospital Münster, Münster, Germany. ^[4] Department of Radiotherapy - Radiooncology, University Hospital Münster, Münster, Germany. ^[5]